Emrah Utku Kabataş

Dr. Emrah Utku Kabataş

orcid

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2014 in Early Human Development
Verified
Journal Article
Closed access
SBSerdar Beken
Serdar Beken
DDDILEK DILLI
DILEK DILLI
NFNurdan Dinlen Fettah
Nurdan Dinlen Fettah
EKEmrah Utku Kabataş
Emrah Utku Kabataş
AZAyşegül Zenciroğlu
Ayşegül Zenciroğlu
NONurullah Okumuş
Nurullah Okumuş

1 January 2017 in Eye & Contact Lens: Science & Clinical Practice
Verified
Journal Article
Closed access
NKNaciye Kabataş
Naciye Kabataş
ADAysun Şanal Doğan
Aysun Şanal Doğan
EKEmrah Utku Kabataş
Emrah Utku Kabataş
MAMutlu Acar
Mutlu Acar
TBTolga Bicer
Tolga Bicer
CGCanan Gürdal
Canan Gürdal
Objective: This study aimed to determine the frequency of Demodex infestation of eyelashes in patients with and without blepharitis and to determine the effects of Demodex infestation on blepharitis and the ocular symptoms. Methods: The study included patients with chronic mixed (anterior + posterior) blepharitis who presented to our clinic. Patients with refractive error and no ocular disease were enrolled as the control group. From each participant, a total of 4 eyelashes were removed and were then examined under a light microscope for Demodex infestation. Symptoms, fluorescein tear breakup time, and ocular surface staining pattern were recorded. Results: The prevalence of Demodex infection in the blepharitis group was 67.2%, versus 54.9% in the control group (P=0.18). The incidence of itching in the blepharitis group was significantly higher in the Demodex (+) patients than in the Demodex (−) patients (P<0.001). Fluorescein tear breakup time in the Demodex (+) patients was significantly shorter than in the Demodex (−) patients (P<0.001). There was not a significant difference in the fluorescein staining pattern between the 2 groups (P=0.57). The incidence of advanced stage blepharitis was significantly higher among the Demodex (+) patients (P=0.007). The incidence of cylindrical eyelash dandruff in the blepharitis group was significantly higher in the Demodex (+) patients (P<0.001). There was a significant difference in meibomian gland dysfunction between the 2 groups (P=0.039). Conclusion: Demodex infestation must be investigated in patients with advanced stage blepharitis, itching, and shorter than normal fluorescein tear breakup time.

24 March 2015 in Journal of Autism and Developmental Disorders
Verified
Journal Article
Closed access
PDF file
EKEmrah Utku Kabataş
Emrah Utku Kabataş
POPinar Altiaylik Ozer
Pinar Altiaylik Ozer
GEGokce Tasdemir Ertugrul
Gokce Tasdemir Ertugrul
BKBengi Ece Kurtul
Bengi Ece Kurtul
SBSahin Bodur
Sahin Bodur
BABurcu Ersoz Alan
Burcu Ersoz Alan

27 January 2017 in Current Eye Research
Verified
Journal Article
Closed access
EKEmrah Utku Kabataş
Emrah Utku Kabataş
BKBengi Ece Kurtul
Bengi Ece Kurtul
PÖPınar Altıaylık Özer
Pınar Altıaylık Özer
NKNaciye Kabataş
Naciye Kabataş
To evaluate effectiveness of treatment modalities, major complications and refractive errors in children who were treated with intravitreal bevacizumab (IVB), intravitreal ranibizumab (IVR) or laser photocoagulation (LP) for type 1 retinopathy of prematurity (ROP). Premature infants who underwent IVB monotherapy (Group 1), IVR monotherapy (Group 2) or LP (Group 3) for type 1 ROP and infants with spontaneously regressed ROP (Group 4) were included for the study. Major complications, recurrence rate, recurrence time, total retinal vascularization time and refractive errors at 18 months of corrected age (CA) were determined. Groups 1, 2, 3 and 4 included 24 eyes of 12 patients, 12 eyes of six patients, 72 eyes of 36 patients and 148 eyes of 74 patients, respectively. Recurrence of the disease occurred in two eyes of one patient in Group 1 at 52 weeks of postmenstrual age (PMA) and two eyes of one patient at 48 weeks of PMA in Group 2. In Group 3, disease did not regress after the first treatment in 10 eyes of five patients. The mean vascularization time in Group 1 was 73 ± 10.1 weeks of PMA and 61.8 ± 6.6 weeks of PMA in Group 2 (p = 0.027). Macular ectopia was seen in two eyes of one patient and exudative retinal detachment (ERD) occurred in two eyes of one patient in Group 3. Mean spherical equivalent was 1.49 ± 3.04 diopters (D) in Group 1, -1.79 ± 2.87D in Group 2, -1.27 ± 2.8 D in Group 3 and 1.52 ± 1.07 D in Group 4 at 18 months of CA. There was no significant difference in astigmatism values in all groups. IVB, IVR and LP are options that can successfully treat ROP. Myopia was observed to be the main refractive error in all treatment groups. Vascularization of the retina was completed later in the IVB group than in the IVR group.

11 November 2013 in Acta Paediatrica
Verified
Journal Article
Closed access
PDF file
DDDILEK DILLI
DILEK DILLI
NINisa Eda Çullas İlArslan
Nisa Eda Çullas İlArslan
EKEmrah Utku Kabataş
Emrah Utku Kabataş
AZAyşegül Zenciroğlu
Ayşegül Zenciroğlu
YŞYıldız Şimşek
Yıldız Şimşek
NONurullah Okumuş
Nurullah Okumuş

1 August 2015 in Journal of American Association for Pediatric Ophthalmology and Strabismus
Verified
Journal Article
Closed access
BKBengi Ece Kurtul
Bengi Ece Kurtul
EKEmrah Utku Kabataş
Emrah Utku Kabataş
AZAysegul Zenciroglu
Aysegul Zenciroglu
POPinar Altiaylik Ozer
Pinar Altiaylik Ozer
GEGokce Tasdemir Ertugrul
Gokce Tasdemir Ertugrul
NONurullah Okumus
Nurullah Okumus